Copyright
©The Author(s) 2023.
World J Cardiol. Nov 26, 2023; 15(11): 582-598
Published online Nov 26, 2023. doi: 10.4330/wjc.v15.i11.582
Published online Nov 26, 2023. doi: 10.4330/wjc.v15.i11.582
Table 1 Demographics and clinical characteristics of the patient population
Characteristics | No PPM | PPM | P value |
n = 300 (%) | n = 57 (%) | ||
Age | 81.0 (8.2) | 80.3 (7.6) | 0.530 |
Male | 158 (52.7) | 30 (52.6) | 1.00 |
BMI | 30.5 (6.6) | 31.4 (6.6) | 0.380 |
STS risk score | 0.168 | ||
High (≥ 8%) | 194 (64.7) | 41 (73.2) | |
Intermediate (4%-7%) | 72 (24) | 12 (21.4) | |
Low (< 4%) | 34 (11.3) | 3 (5.4) | |
Cardiovascular history | |||
AF | 128 (42.7) | 28 (49.1) | 0.385 |
CAD | 260 (86.7) | 51 (89.5) | 0.670 |
MI | 62 (20.7) | 16 (28.1) | 0.223 |
HF | 280 (93.3) | 54 (94.7) | 1.00 |
NYHA HF class | 0.495 | ||
1 | 4 (1.5) | 1 (1.9) | |
2 | 101 (38.1) | 18 (34) | |
3 | 148 (55.8) | 30 (56.6) | |
4 | 12 (4.5) | 4 (7.5) | |
PCI or stent | 134 (44.7) | 29 (50.9) | 0.469 |
CABG | 47 (15.7) | 13 (22.8) | 0.182 |
Previous AV replacement | 24 (8.0) | 1 (1.8) | 0.151 |
Hypertension | 284 (94.7) | 56 (98.2) | 0.493 |
Dyslipidemia | 271 (90.3) | 51 (89.5) | 0.810 |
Diabetes | 122 (40.7) | 34 (59.6) | 0.009 |
PVD | 73 (24.3) | 20 (35.1) | 0.101 |
Stroke/TIA | 32 (10.7) | 8 (14) | 0.491 |
Balloon valvuloplasty | 149 (50) | 35 (62.5) | 0.108 |
Other comorbidities | |||
COPD | 89 (29.7) | 11 (19.3) | 0.147 |
Liver disease | 4 (1.3) | 1 (1.8) | 0.583 |
Cancer | 142 (47.3) | 26 (45.6) | 0.885 |
Anemia | 259 (86.3) | 51 (89.5) | 0.670 |
Dialysis | 15 (5) | 4 (7) | 0.521 |
Table 2 Baseline electrocardiographic and echocardiogram findings
All | No PPM | PPM | P value | |
n = 357 | n = 300 | n = 57 | ||
EKG rhythm abnormalities | 0.054 | |||
Sinus | 265 (74.2) | 229 (76.3) | 36 (63.2) | |
Atrial fibrillation | 84 (23.5) | 66 (22.0) | 18 (31.6) | |
Atrial flutter | 4 (1.1) | 2 (0.7) | 2 (3.5) | |
Junctional rhythm | 2 (0.6) | 1 (0.3) | 1 (1.8) | |
Other | 2 (0.6) | 2 (0.7) | 0 (0) | |
Sinus bradycardia | 38 (10.6) | 35 (11.7) | 3 (5.3) | 0.229 |
Sinus tachycardia | 3 (0.8) | 3 (1) | 0 (0) | 1.00 |
Conduction abnormalities | ||||
RBBB | 51 (14.3) | 33 (11) | 18 (31.6) | < 0.001 |
LBBB | 29 (8.1) | 24 (8) | 5 (8.8) | 0.794 |
AV block I | 55 (15.4) | 46 (15.3) | 9 (15.8) | 1.00 |
AV block IIa | 0 | 0 | 0 | - |
AV block IIb | 0 | 0 | 0 | - |
AV block III | 0 | 0 | 0 | - |
Bifascicular block | 5 (1.4) | 5 (1.7) | 0 (0) | 1.00 |
Left anterior fascicular block | 16 (4.5) | 12 (4) | 4 (7) | 0.299 |
Left posterior fascicular block | 1 (0.3) | 0 (0) | 1 (1.8) | 0.16 |
Abnormal QRS (≥ 120 ms) | 89 (25) | 62 (20.7) | 27 (47.4) | < 0.001 |
Prolonged QTc (≥ 470 ms) | 97 (27.2) | 70 (23.4) | 27 (47.4) | < 0.001 |
Echocardiogram findings | ||||
Left ventricular EF | 58.1 (12.7) | 58.5 (11.9) | 56 (16.1) | 0.272 |
AV peak velocity | 4.1 (0.7) | 4.1 (0.7) | 4.1 (0.7) | 0.957 |
AV mean gradient | 42 (14.7) | 42.1 (14.7) | 41.3 (14.8) | 0.707 |
AV peak gradient | 68.4 (21.9) | 68.4 (21.7) | 68.1 (23.2) | 0.933 |
AV regurgitation | 0.247 | |||
None | 147 (43.9) | 116 (41.6) | 31 (55.4) | |
Mild | 162 (48.4) | 141 (50.5) | 21 (37.5) | |
Moderate | 23 (6.9) | 19 (6.8) | 4 (7.1) | |
Severe | 3 (0.9) | 3 (1.1) | 0 (0) | |
MV regurgitation | 0.242 | |||
None | 28 (8.2) | 24 (8.4) | 4 (7.1) | |
Mild | 255 (74.8) | 208 (73.0) | 47 (83.9) | |
Moderate | 52 (15.2) | 48 (16.8) | 4 (7.1) | |
Severe | 6 (1.8) | 5 (1.8) | 1 (1.8) | |
TV regurgitation | 0.129 | |||
None | 19 (5.6) | 19 (6.6) | 0 (0) | |
Mild | 272 (79.8) | 226 (79.0) | 46 (83.6) | |
Moderate | 43 (12.6) | 36 (12.6) | 7 (12.7) | |
Severe | 7 (2.1) | 5 (1.7) | 2 (3.6) | |
Pulmonary artery pressure | 46.9 (14.1) | 45.9 (13.1) | 51.6 (17.7) | 0.073 |
Annulus area | 0.8 (0.2) | 0.8 (0.2) | 0.8 (0.3) | 0.968 |
Aortic sinus diameter | 3.2 (0.5) | 3.2 (0.5) | 3.3 (0.5) | 0.074 |
CT annulus diameter 1 | 25.1 (4.4) | 25 (4.3) | 25.2 (4.8) | 0.849 |
CT annulus diameter 2 | 24.2 (4.2) | 24.1 (4.2) | 24.8 (4.3) | 0.273 |
LV diastolic diameter | 4.7 (0.8) | 4.7 (0.8) | 4.8 (0.8) | 0.290 |
LVOT | 20.9 (1.9) | 20.8 (1.9) | 21.1 (1.9) | 0.354 |
Table 3 Procedural characteristics and peri-procedural complications
All | No PPM | PPM | P value | |
n = 357 | n = 300 | n = 57 | ||
Urgency | 0.699 | |||
Elective | 344 (96.6) | 288 (96.3) | 56 (98.2) | |
Emergency | 12 (3.4) | 11 (3.7) | 1 (1.8) | |
Valve | 0.471 | |||
Balloon expandable | 192 (53.8) | 164 (54.7) | 28 (49.1) | |
Self-expandable | 165 (46.2) | 136 (45.3) | 29 (50.9) | |
Valve size | 26.9 (3) | 26.8 (2.9) | 27.3 (3) | 0.266 |
Valve index | 129.4 (14.9) | 129.3 (15.1) | 129.9 (13.5) | 0.792 |
Valve sheath access site | 0.270 | |||
Right femoral | 241 (68.5) | 206 (69.8) | 35 (61.4) | |
Left femoral | 94 (26.7) | 72 (24.4) | 22 (38.6) | |
Right subclavian | 2 (0.6) | 2 (0.7) | 0 (0) | |
Left subclavian | 4 (1.1) | 4 (1.4) | 0 (0) | |
Right radial | 2 (0.6) | 2 (0.7) | 0 (0) | |
Transaortic | 9 (2.6) | 9 (3.1) | 0 (0) | |
Procedure time | 1.5 (0.8) | 1.4 (0.8) | 1.6 (0.9) | 0.056 |
Perioperative complications | ||||
Atrial fibrillation | 1 (0.3) | 1 (0.3) | 0 (0) | 1.00 |
Atrial flutter | 1 (0.3) | 1 (0.3) | 0 (0) | 1.00 |
AV block I | 6 (1.7) | 6 (2) | 0 (0) | 0.595 |
AV block II | 0 | 0 | 0 | - |
Complete AV block | 24 (6.7) | 1 (0.3) | 23 (40.4) | < 0.001 |
Ventricular tachycardia | 0 | 0 | 0 | - |
Ventricular fibrillation | 0 | 0 | 0 | - |
Bleeding | 8 (2.2) | 8 (2.7) | 0 (0) | 0.365 |
Stroke | 1 (0.3) | 1 (0.3) | 0 (0) | 1.00 |
Transfusion | 3 (0.8) | 3 (1) | 0 (0) | 1.00 |
Site bleeding | 0 | 0 | 0 | - |
Left axis deviation | 3 (0.8) | 2 (0.7) | 1 (1.8) | 0.408 |
LBBB | 0 | 0 | 0 | - |
RBBB | 0 | 0 | 0 | - |
Left anterior fascicular block | 0 | 0 | 0 | - |
Left posterior fascicular block | 0 | 0 | 0 | - |
MI | 1 (0.3) | 1 (0.3) | 0 (0) | 1.00 |
Other | 31 (8.7) | 24 (8) | 7 (12.3) | 0.305 |
Table 4 Incidence of permanent pacemakers implantation
Variable | Group | n | Incidence (%) | P value |
Age | < 65 yr | 10 | 0 (0) | 0.284 |
65-85 yr | 235 | 41 (17.4) | ||
> 85 yr | 112 | 16 (14.3) | ||
Sex | Male | 169 | 27 (16.0) | 1.00 |
Female | 188 | 30 (16.0) | ||
Pre-operative risk | Low | 37 | 3 (8.1) | 0.168 |
Intermediate | 84 | 12 (14.3) | ||
High | 235 | 41 (17.4) | ||
Valve type | Balloon expanding | 192 | 28 (14.6) | 0.471 |
Self-expanding | 165 | 29 (17.6) | ||
Prior BAV | Yes | 184 | 35 (19.0) | 0.116 |
No | 170 | 21 (12.4) | ||
Procedure time | < 1.5 h | 160 | 20 (12.5) | 0.071 |
≥ 1.5 h | 160 | 33 (20.6) | ||
Pre-op EKG rhythm abnormalities | Sinus | 265 | 36 (13.6) | 0.054 |
Atrial fibrillation | 83 | 18 (21.4) | ||
Atrial flutter | 4 | 2 (50.0) | ||
Junctional rhythm | 2 | 1 (50.0) | ||
Other | 2 | 0 (0) | ||
RBBB | Yes | 51 | 18 (35.3) | < 0.001 |
No | 306 | 39 (12.7) | ||
LBBB | Yes | 29 | 5 (17.2) | 0.794 |
No | 328 | 52 (15.9) | ||
AV block I | Yes | 55 | 9 (16.4) | 1.000 |
No | 302 | 48 (15.9) | ||
Bifascicular block | Yes | 5 | 0 (0) | 1.000 |
No | 352 | 57 (16.2) | ||
Left anterior fascicular block | Yes | 16 | 4 (25.0) | 0.299 |
No | 341 | 53 (15.5) | ||
Left posterior fascicular block | Yes | 1 | 1 (100) | 0.160 |
No | 356 | 56 (15.7) | ||
QRS interval | Abnormal (≥ 120 ms) | 89 | 27 (30.3) | < 0.001 |
Normal | 267 | 30 (11.2) | ||
QTc interval | Prolonged (≥ 470 ms) | 97 | 27 (27.8) | < 0.001 |
Normal | 259 | 30 (11.6) |
Table 5 Incidence of permanent pacemakers implantation by QRS duration
Variable | Group | n | Incidence | P value |
QRS interval | ≤ 100 | 194 | 17 (8.8) | < 0.001 |
101-120 | 74 | 14 (18.9) | ||
121-140 | 38 | 9 (23.7) | ||
141-160 | 40 | 16 (40.0) | ||
161-180 | 10 | 1 (10.0) | ||
Pre-op EKG supraventricular arrhythmia | Supraventricular arrhythmia1 | 91 | 21 (22.8) | 0.05 |
Sinus rhythm | 265 | 36 (13.6) |
Table 6 Odds ratios for permanent pacemakers implantation
OR | 95%CI | P value | |
Age (per 5 yr) | 0.95 | 0.8-1.12 | 0.549 |
Male | 1.00 | 0.57-1.76 | 0.996 |
Prior AV replacement | 0.21 | 0.03-1.55 | 0.125 |
CAD | 1.31 | 0.53-3.25 | 0.563 |
HF | 1.29 | 0.37-4.48 | 0.693 |
Self-expanding (Reference: balloon) | 1.25 | 0.71-2.20 | 0.442 |
Prior conduction defect-RBBB | 3.73 | 1.92-7.26 | < 0.001 |
Prior conduction defect-LBBB | 1.11 | 0.40-3.03 | 0.845 |
Prior conduction defect-LFAB | 1.81 | 0.56-5.83 | 0.319 |
Valve index | 1.00 | 0.98-1.02 | 0.806 |
Abnormal QRS (≥ 120 ms) | 3.45 | 1.91-6.23 | < 0.001 |
Prolonged QTc (≥ 470 ms) | 2.94 | 1.64-5.28 | < 0.001 |
Aortic valve area > 0.75 | 1.31 | 0.73-2.36 | 0.364 |
High preoperative risk (Reference: Low) | 2.40 | 0.70-8.17 | 0.163 |
Intermediate preoperative risk (Reference: Low) | 1.89 | 0.50-7.14 | 0.348 |
Supraventricular Arrhythmia on pre-op EKG (Reference: Sinus) | 1.88 | 1.03-3.43 | 0.039 |
Table 7 Adjusted odds ratios for permanent pacemakers implantation
aOR | 95%CI | P value | |
Diabetes | 2.16 | 1.18-3.94 | 0.012 |
Prior RBBB | 2.15 | 0.91-5.09 | 0.081 |
Abnormal QRS (≥ 120 ms) | 2.18 | 1.02-4.66 | 0.045 |
Supraventricular arrhythmia on pre-op EKG (Reference: Sinus rhythm) | 1.82 | 0.97-3.42 | 0.062 |
- Citation: Nwaedozie S, Zhang H, Najjar Mojarrab J, Sharma P, Yeung P, Umukoro P, Soodi D, Gabor R, Anderson K, Garcia-Montilla R. Novel predictors of permanent pacemaker implantation following transcatheter aortic valve replacement. World J Cardiol 2023; 15(11): 582-598
- URL: https://www.wjgnet.com/1949-8462/full/v15/i11/582.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i11.582